ARPA-H has awarded 25 million dollars to the VITAL project to develop 3D printed, patient-derived va...

ARPA-H has awarded 25 million dollars to the VITAL project to develop 3D printed, patient-derived vascularized livers through a collaboration between UT Southwestern and Trestle Biotherapeutics. This initiative targets the production of functional organ constructs with integrated vascular networks and bile ducts in just 10 to 13 weeks. By combining GMP-compliant manufacturing with high-resolution bioprinting, this project moves regenerative medicine toward a repeatable clinical supply chain. This systemic shift will transform organ transplant accessibility and provide high-fidelity human models for drug testing. #3DPrinting #Bioprinting #HealthTech #AdditiveManufacturing #ARPAH